Wednesday, February 20, 2013

Robin Roberts from Good Morning America Attributes Clinical Trials to her Recovery

Five months after recovering from a bone marrow transplant, Robin Roberts returned to Good Morning America (GMA)! The morning-show co-host has overcome breast cancer, and most recently a condition known as myelodysplastic syndrome (MDS). Few probably had ever heard of this condition, much less know what it is.  MDS is a disorder where the bone marrow produces too few functioning red blood cells, white blood cells and platelets. Robin's treatment involved chemotherapy, a stem cell transplant and a long recovery.

Today Robin returned to GMA looking healthy and happy.  She discussed her diagnosis and treatment along side her doctors and attributed clinical trials to her successful outcome.  "Thank you for making me a part of clinical trials," she said.  "I have benefitted from those who have made treatments available" she indicated, through their participation in clinical trials.  She and her doctor expressed to the audience that the standard treatments of today were developed because those before us had chosen to participate in clinical trials.  Her physician noted "Our obligation is to develop the standard of care for the patients of tomorrow."   Click here to see the entire video from GMA.

Sources:,, Memorial Sloan-Kettering Cancer Center


  1. This is a great story which can truly highlight the importance of ongoing clinical research. There are many Americans who do not have any real knowledge of clinical trials, and there are many more that simply get the wrong impression from them. I think that in light of those recent sequestrations that have placed new limits on the NIH and others, this could really show more people why that could be a really bad thing.

    1. The sequestration has had a significant impact on many programs. For me, I have been most disheartened by the cuts that were made to ongoing cancer research projects. It sad to think that we may not be able to advance cancer treatments due to these budget cuts.

  2. Thank you for your response Stephen! PMG is dedicated to sharing clinical trial information in an effort to educate the public about the benefits of participation in research studies. It's important for people to know that clinical trials can be a treatment option worth considering...and their contribution to medical advancement can make a difference in the healthcare advancements of tomorrow.


Subscribe Via Email